| Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to … C Fitzmaurice, C Allen, RM Barber, L Barregard, ZA Bhutta, H Brenner, ... JAMA oncology 3 (4), 524-548, 2017 | 8200 | 2017 |
| Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4· 4 million participants B Zhou, Y Lu, K Hajifathalian, J Bentham, M Di Cesare, G Danaei, H Bixby, ... The lancet 387 (10027), 1513-1530, 2016 | 4391 | 2016 |
| Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ... The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017 | 2185 | 2017 |
| Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ... The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018 | 1625 | 2018 |
| The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 SG Sepanlou, S Safiri, C Bisignano, KS Ikuta, S Merat, M Saberifiroozi, ... The Lancet gastroenterology & hepatology 5 (3), 245-266, 2020 | 1435 | 2020 |
| The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease … S Alatab, SG Sepanlou, K Ikuta, H Vahedi, C Bisignano, S Safiri, ... The Lancet gastroenterology & hepatology 5 (1), 17-30, 2020 | 1027 | 2020 |
| The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the … A Pourshams, SG Sepanlou, KS Ikuta, C Bisignano, S Safiri, G Roshandel, ... The lancet Gastroenterology & hepatology 4 (12), 934-947, 2019 | 917* | 2019 |
| Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study S Blach, NA Terrault, F Tacke, I Gamkrelidze, A Craxi, J Tanaka, I Waked, ... The Lancet Gastroenterology & Hepatology 7 (5), 396-415, 2022 | 438 | 2022 |
| Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study F Islami, A Pourshams, D Nasrollahzadeh, F Kamangar, S Fahimi, ... Bmj 338, 2009 | 378 | 2009 |
| Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial G Roshandel, M Khoshnia, H Poustchi, K Hemming, F Kamangar, ... The Lancet 394 (10199), 672-683, 2019 | 283 | 2019 |
| Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the northwest of Iran R Malekzadeh, M Sotoudeh, MH Derakhshan, J Mikaeli, A Yazdanbod, ... Journal of clinical pathology 57 (1), 37-42, 2004 | 262 | 2004 |
| Socio-economic status and oesophageal cancer: results from a population-based case–control study in a high-risk area F Islami, F Kamangar, D Nasrollahzadeh, K Aghcheli, M Sotoudeh, ... International journal of epidemiology 38 (4), 978-988, 2009 | 259 | 2009 |
| Hepatitis B in Iran SH Merat, R Malekzadeh, H Rezvan, M Khatibian ARCHIVES OF IRANIAN MEDICINE 3 (4), 0-0, 2000 | 238 | 2000 |
| The effect of fluoxetine in patients with pain and constipation‐predominant irritable bowel syndrome: a double‐blind randomized‐controlled study H Vahedi, S Merat, A Rashidioon, A Ghoddoosi, R Malekzadeh Alimentary pharmacology & therapeutics 22 (5), 381-385, 2005 | 232 | 2005 |
| Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial F Mofidi, H Poustchi, Z Yari, B Nourinayyer, S Merat, M Sharafkhah, ... British Journal of Nutrition 117 (5), 662-668, 2017 | 230 | 2017 |
| The effect of enteric-coated, delayed-release peppermint oil on irritable bowel syndrome S Merat, S Khalili, P Mostajabi, A Ghorbani, R Ansari, R Malekzadeh Digestive diseases and sciences 55, 1385-1390, 2010 | 226 | 2010 |
| Epidemiologic features of upper gastrointestinal tract cancers in Northeastern Iran F Islami, F Kamangar, K Aghcheli, S Fahimi, S Semnani, N Taghavi, ... British journal of cancer 90 (7), 1402-1406, 2004 | 225 | 2004 |
| Repositioning of the global epicentre of non-optimal cholesterol Nature 582 (7810), 73-77, 2020 | 221 | 2020 |
| Statins for non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis L Eslami, S Merat, R Malekzadeh, S Nasseri‐Moghaddam, H Aramin Cochrane Database of Systematic Reviews, 2013 | 216 | 2013 |
| Clinical trial: the effect of amitriptyline in patients with diarrhoea‐predominant irritable bowel syndrome H Vahedi, S Merat, S Momtahen, AS Kazzazi, N Ghaffari, G Olfati, ... Alimentary pharmacology & therapeutics 27 (8), 678-684, 2008 | 212 | 2008 |
